American Well Corp Files 2024 10-K
Ticker: AMWL · Form: 10-K · Filed: Feb 12, 2025 · CIK: 1393584
Sentiment: neutral
Topics: 10-K, annual-report, healthcare-technology
TL;DR
AMWL filed its 2024 10-K. Full financials and biz details inside.
AI Summary
American Well Corp filed its 2024 10-K on February 12, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered in Boston, MA, operates in the business services sector. Key financial details and operational performance for the year are outlined in this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of American Well Corp's financial health, operational strategies, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — 10-K filings inherently carry medium risk due to the detailed financial and operational information that can impact stock valuation.
Key Numbers
- 000000000 — IRS Number (Company's IRS identification number)
- 001-39515 — SEC File Number (Company's SEC file number)
Key Players & Entities
- American Well Corp (company) — Filer of the 10-K
- 0000950170-25-019024 (filing_id) — Accession Number for the filing
- 20241231 (date) — Fiscal year end date
- 20250212 (date) — Filing date
- Boston, MA (location) — Company headquarters and mailing address
FAQ
What was American Well Corp's total revenue for the fiscal year ending December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ending December 31, 2024.
What is the primary business segment of American Well Corp?
American Well Corp is classified under SERVICES-BUSINESS SERVICES, NEC [7389].
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on February 12, 2025.
Where is American Well Corp headquartered?
American Well Corp is headquartered in Boston, MA, with its business and mailing addresses listed at 75 State Street, 26th Floor.
What is the fiscal year end for American Well Corp?
The fiscal year end for American Well Corp is December 31.
Filing Stats: 4,352 words · 17 min read · ~15 pages · Grade level 15.6 · Accepted 2025-02-12 17:28:11
Key Financial Figures
- $0.01 — ed Class A common stock, par value of $0.01 per share AMWL The New York Stock E
- $94 billion — r business in the U.S. at approximately $94 billion. This includes: Virtual Care — virtua
- $31 billion — r hybrid care platform is approximately $31 billion and will grow to roughly $50 billion ov
- $50 billion — ly $31 billion and will grow to roughly $50 billion over the next four years. In addition
- $40 b — a material portion of the approximately $40 billion, and growing, virtual care market
- $23 billion — health space, which is estimated to be $23 billion internationally. Competition We vie
Filing Documents
- amwl-20241231.htm (10-K) — 4326KB
- amwl-ex19_1.htm (EX-19.1) — 80KB
- amwl-ex21_1.htm (EX-21.1) — 14KB
- amwl-ex23_1.htm (EX-23.1) — 3KB
- amwl-ex31_1.htm (EX-31.1) — 17KB
- amwl-ex31_2.htm (EX-31.2) — 17KB
- amwl-ex32_1.htm (EX-32.1) — 10KB
- amwl-ex32_2.htm (EX-32.2) — 9KB
- img151466379_0.jpg (GRAPHIC) — 242KB
- 0000950170-25-019024.txt ( ) — 15837KB
- amwl-20241231.xsd (EX-101.SCH) — 1722KB
- amwl-20241231_htm.xml (XML) — 2888KB
Business
Business 2 Item 1A.
Risk Factors
Risk Factors 23 Item 1B. Unresolved Staff Comments 52 Item 1C. Cybersecurity 52 Item 2.
Properties
Properties 53 Item 3.
Legal Proceedings
Legal Proceedings 54 Item 4. Mine Safety Disclosures 54 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 55 Item 6. Reserved 56 Item 7.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 57 Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 70 Item 8.
Financial Statements and Supplementary Data
Financial Statements and Supplementary Data 70 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 71 Item 9A.
Controls and Procedures
Controls and Procedures 71 Item 9B. Other Information 72 Item 9C. Foreign Jurisdictions that Prevent Inspections 72 PART III Item 10. Directors, Executive Officers and Corporate Governance 73 Item 11.
Executive Compensation
Executive Compensation 73 Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 73 Item 13. Certain Relationships and Related Transactions, and Director Independence 73 Item 14. Principal Accounting Fees and Services 73 PART IV Item 15. Exhibits, Financial Statement Schedules 74 Item 16 Form 10-K Summary 78 i SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements contained in this Annual Report on Form 10-K other than statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as "anticipate," "expect," "suggests," "plan," "believe," "intend," "estimates," "targets," "projects," "should," "could," "would," "may," "will," "forecast," or the negative of these terms, and other similar expressions, although not all forward-looking statements contain these words. These forward-looking statements and projections are contained throughout this Form 10-K, including the sections entitled "Item 1. Business," "Item 1A. Risk Factors," and "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations." The forward-looking statements and projections are subject to and involve risks, uncertainties and assumptions and you should not place undue reliance on these forward-looking statements or projections. Although we believe that these forward-looking statements and projections are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our actual finan
B usiness
Item 1. B usiness. Overview Amwell is a leading enterprise platform and software company digitally enabling hybrid care. We empower health providers, payers, and innovators to achieve their digital ambitions, enabling a coordinated experience across in-person, virtual and automated care. We provide our clients with the core technology and services necessary to successfully develop and distribute digital care programs that meet their strategic, operational, financial and clinical objectives under their own brands. Founded in 2006, Amwell pioneered virtual healthcare. Today, Amwell extends digital care beyond telehealth, enabling care across in-person, virtual and automated modalities and providing an open, scalable platform that can flex and grow alongside our clients. We bring technology and services that facilitate new models of care, strategic partnerships, consistent execution and better outcomes. Together with our clients and innovation partners, we forge a new hybrid model of care delivery that adapts as needs evolve and makes care more accessible for all. As of December 31, 2024, we power the digital care programs of approximately 50 health plans, which collectively represent more than 80 million covered lives, as well as approximately 100 of the nation's largest health systems. Since inception, we have powered more than 33.1 million virtual care visits for our clients, including more than 5.9 million in the year ended December 31, 2024. Our enterprise platform and software as a service solutions enable hybrid care delivery by offering our clients products to help weave digital care across all care settings. For health systems, our enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Our suite of Carepoint devices can enhance in-person care, whether the clients want to turn existing equipment such as televisions or iPads into digital access points or use Amwell Carepoint TM